FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Digoxin Injection
Status: Currently in Shortage
»Date first posted: 06/04/2021
»Therapeutic Categories: Cardiovascular

Expand all

Covis Pharma (Revised 10/06/2021)

Company Contact Information:
913-661-3814

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lanoxin (digoxin) Injection Adult (500mcg in 2ml) Ampule (NDC 0515-260-10) Available Delay in shipping of the drug
Lanoxin (digoxin) Injection Adult (500mcg in 2ml) vial (NDC 70515-261-10) Available
Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) ampoule (NDC 70515-262-10) Available
Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) vial (NDC 70515-263-10) Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (New 06/04/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mcg/mL, 2 mL (NDC 0641-1410-35) This presentation is on backorder. Product recovery is undetermined at this time. Other

Sandoz (Reverified 10/21/2021)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mcg/2 mL; 10 ampules (NDC 0781-3059-95) Available; Intermittent Backorder Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English